Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bsuac6
    Junior Member
    • Sep 2010
    • 9

    #1

    Comparing RNA-seq data with different read lengths

    Hi All,

    I work with SOLiD RNA-seq data. I have sequencing from the version 4 machine and sequencing from the 5500xl. These have different reads lengths 50bp and 75bp, respectively.

    Because these reads are different lengths I assume they will map differently. So I was wondering whether you can compare expression if you have samples from the v4 and 5500xl? How would you take into account biases from read length?

    I have tried to test the affect of read length on mapping/ raw counts produced. Using the 5500xl data only, I compared 75bp to the same samples artificially trimmed to 50bp. I get more reads mapping in the trimmed 50bp, this doesn't surprise me as the quality will be higher (25bp from the 3' are trimmed). Though by altering the max quality for mismatched base pairs i can get mapping within 0.24% e.g. trimmed 62.76% mapping, untrimmed 62.52% mapping.

    I then use HTseq to count the number of reads mapping to genes. I use edgeR to assess differential expression between untrimmed and trimmed reads (removing low expressed reads). There are approx 110 genes differentially expressed between trimmed and untrimmed. This differential expression worries me because if even within the same samples you can get differential expression due to read length changes then how can i compare data generated on the version 4 with the 5500xl? Or how, for that matter, could anyone ever compare data from other platforms with out introducing biases from read length variation?

    I have been searching to see if anyone else has looked at biases introduced from read length but I cant find anything - everyone has focused on gene length, GC content etc.

    Any thoughts and/or help would be appreciated. Thanks.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...